I just thought it kind of odd, that the FDA clinical site shows currently recruiting. Was this not closed to recruitment awhile back? I like the data for the trial so far seem good to laymen like myself. I hope out first line data sees OS improvement over the control arm.
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
This study is currently recruiting participants.
Verified May 2013 by University of Arizona
Sponsor:
University of Arizona
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Arizona
ClinicalTrials.gov Identifier:
NCT01288261
First received: January 27, 2011
Last updated: May 21, 2013
Last verified: May 2013
History of Changes
News 
Market Data 
Discover 
AI
